| Trial ID: | L0830 |
| Source ID: | IRCT2017011531958N1
|
| Associated Drug: |
Phytosterols
|
| Title: |
Effect of phytosterols supplementation on serum levels of inflammatory markers ,liver enzymes ,lipid profiles ,Adiponectin ,Leptin and fasting blood sugar in non-alcoholic fatty liver disease patients
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty liver Disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Intervention group : daily consumption of 400 mg phytosterols supplement (twice a day and each time 2 tabs=1.6 g) for 60 days. Intervention 2: control group : daily consumption of 400 mg starch (twice a day and each time 2 tabs=1.6 g) for
|
| Outcome Measures: |
Aspartate aminotransferase. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Alanine aminotransferase. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Gamma-glutamyl transpeptidase. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Interlukine-6. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Hs-CRP. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;TNF-a. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Total cholestrol. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;LDL-C. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;HDL-C. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Triglyciride. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;VLDL. Timepoint: Before intervention and 2 months after intervention. Method of measurement: TG/5.;Adiponectin. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Leptin. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.;Fasting blood sugar. Timepoint: Before intervention and 2 months after intervention. Method of measurement: blood test.Blood pressure. Timepoint: Before intervention and 2 months after intervention. Method of measurement: By manometer according to mmHg.;Body weight. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Digital scale.;Body mass index. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Body weight in kilograms divided by height squared in meters.;Waist circumference. Timepoint: Before intervention and 2 months after intervention. Method of measurement: By measuring tape according to meter.;Hip circumference. Timepoint: Before intervention and 2 months after intervention. Method of measurement: By measuring tape according to meter.
|
| Sponsor/Collaborators: |
Vice chancellor for research, Ahvaz Jondishapur University Of Medical Sciences
|
| Gender: |
All
|
| Age: |
19 years59 years
|
| Phases: |
Phase 2
|
| Enrollment: |
42
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
20/02/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/25007
|
